Gage Philip Jull

All filings by Gage Philip Jull on record concern Tryp Therapeutics Inc. In total, 8 filings cover trades dated from 25 September 2020 to 19 October 2022.

The open-market record is one-sided, with 3 purchases worth €8,487 and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 3 option exercises. 2022 to date brings 3 purchases and no sales.

A typical purchase (the median) is worth €3,857. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The record was last updated on 25 October 2022 with an open-market purchase (€3,857) in Tryp Therapeutics Inc. Filings reach the SEDI feed a median of 5 days after the trade. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.